These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 10998138)

  • 41. 2-deoxy D-glucose treatment does not elicit a hair growth response in alopecia areata.
    Sundberg JP; Silva KA; Kennedy VE; Wilson JJ; Gott NE; Sundberg BA; Roopenian DC
    Exp Dermatol; 2019 Sep; 28(9):1091-1093. PubMed ID: 31323149
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapy for Alopecia Areata in Mice by Stimulating the Hair Cycle with Parathyroid Hormone Agonists Linked to a Collagen-Binding Domain.
    Katikaneni R; Seymour AW; Gulati R; Ponnapakkam T; Gensure RC
    J Investig Dermatol Symp Proc; 2015 Nov; 17(2):13-5. PubMed ID: 26551937
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dietary soy oil content and soy-derived phytoestrogen genistein increase resistance to alopecia areata onset in C3H/HeJ mice.
    McElwee KJ; Niiyama S; Freyschmidt-Paul P; Wenzel E; Kissling S; Sundberg JP; Hoffmann R
    Exp Dermatol; 2003 Feb; 12(1):30-6. PubMed ID: 12631244
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amygdalin ameliorates alopecia areata on C3H/HeJ mice by inhibiting inflammation through JAK2/STAT3 pathway.
    He X; Liu J; Gong Y; Lu W; Sha X; Cao C; Li Y; Wang J
    J Ethnopharmacol; 2024 Sep; 331():118317. PubMed ID: 38723918
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin.
    Tang L; Cao L; Sundberg JP; Lui H; Shapiro J
    Exp Dermatol; 2004 Jan; 13(1):5-10. PubMed ID: 15009110
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of alopecia areata in C3H/HeJ mice using polyinosinic-polycytidylic acid (poly[I:C]) and interferon-gamma.
    Shin JM; Choi DK; Sohn KC; Koh JW; Lee YH; Seo YJ; Kim CD; Lee JH; Lee Y
    Sci Rep; 2018 Aug; 8(1):12518. PubMed ID: 30131581
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis.
    Gupta AK; Ellis CN; Cooper KD; Nickoloff BJ; Ho VC; Chan LS; Hamilton TA; Tellner DC; Griffiths CE; Voorhees JJ
    J Am Acad Dermatol; 1990 Feb; 22(2 Pt 1):242-50. PubMed ID: 2138175
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD44v10 expression in the mouse and functional activity in delayed type hypersensitivity.
    Rösel M; Seiter S; Zöller M
    J Cell Physiol; 1997 Jun; 171(3):305-17. PubMed ID: 9180900
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nonsurgical Induction of Alopecia Areata in C3H/HeJ Mice via Adoptive Transfer of Cultured Lymphoid Cells.
    Wang EHC; McElwee KJ
    Methods Mol Biol; 2020; 2154():121-131. PubMed ID: 32314212
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of alopecia areata in C3H/HeJ mice using cryopreserved lymphocytes.
    Hashimoto K; Yamada Y; Sekiguchi K; Matsuda S; Mori S; Matsumoto T
    J Dermatol Sci; 2021 Jun; 102(3):177-183. PubMed ID: 33994063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata.
    de Jong A; Jabbari A; Dai Z; Xing L; Lee D; Li MM; Duvic M; Hordinsky M; Norris DA; Price V; Mackay-Wiggan J; Clynes R; Christiano AM
    JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapy of alopecia areata: on the cusp and in the future.
    Price VH
    J Investig Dermatol Symp Proc; 2003 Oct; 8(2):207-11. PubMed ID: 14582675
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current Protocols: Alopecia Areata Mouse Models for Drug Efficacy and Mechanism Studies.
    Sundberg JP; Wang EHC; McElwee KJ
    Curr Protoc; 2024 Aug; 4(8):e1113. PubMed ID: 39105684
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The pathogenesis of alopecia areata in rodent models.
    McElwee KJ; Freyschmidt-Paul P; Sundberg JP; Hoffmann R
    J Investig Dermatol Symp Proc; 2003 Jun; 8(1):6-11. PubMed ID: 12894987
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of the Lexington LaserComb on hair regrowth in the C3H/HeJ mouse model of alopecia areata.
    Wikramanayake TC; Rodriguez R; Choudhary S; Mauro LM; Nouri K; Schachner LA; Jimenez JJ
    Lasers Med Sci; 2012 Mar; 27(2):431-6. PubMed ID: 21739260
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunohistological study of the development of the cellular infiltrate in the pelage follicles of the DEBR model for alopecia areata.
    Zhang JG; Oliver RF
    Br J Dermatol; 1994 Apr; 130(4):405-14. PubMed ID: 7910477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alopecia areata: infiltration of Th17 cells in the dermis, particularly around hair follicles.
    Tanemura A; Oiso N; Nakano M; Itoi S; Kawada A; Katayama I
    Dermatology; 2013; 226(4):333-6. PubMed ID: 23838575
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice.
    Gilhar A; Ullmann Y; Berkutzki T; Assy B; Kalish RS
    J Clin Invest; 1998 Jan; 101(1):62-7. PubMed ID: 9421466
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Crisp1 and alopecia areata in C3H/HeJ mice.
    Sundberg JP; Awgulewitsch A; Pruett ND; Potter CS; Silva KA; Stearns TM; Sundberg BA; Muñoz MW; Cuasnicu PS; King LE; Rice RH
    Exp Mol Pathol; 2014 Dec; 97(3):525-8. PubMed ID: 25446841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alopecia areata susceptibility in rodent models.
    McElwee KJ; Freyschmidt-Paul P; Zöller M; Hoffmann R
    J Investig Dermatol Symp Proc; 2003 Oct; 8(2):182-7. PubMed ID: 14582670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.